As of April 19, 2025, Arcus Biosciences (RCUS) has a market cap of $0.83 billion USD. According to our data, Arcus Biosciences is ranked No.5291 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $0.83 B |
-38.79%
|
Dec 31, 2024 | $1.36 B |
-22.04%
|
Dec 29, 2023 | $1.75 B |
-7.64%
|
Dec 30, 2022 | $1.89 B |
-48.90%
|
Dec 31, 2021 | $3.70 B |
55.89%
|
Dec 31, 2020 | $2.38 B |
157.03%
|
Dec 31, 2019 | $0.92 B |
-6.22%
|
Dec 31, 2018 | $0.99 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Exelixis
EXEL
|
$9.97 B |
-0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.27 B |
0.000 M
|
![]() USA
|
Market Cap | = | RCUS Stock Price | * | RCUS Shares Outstanding |
= | $7.88 | * | 0.11 B | |
= | $0.83 B |